Health 2.0 Conference Reviews Hyper-Automation Facilitating Healthcare Scams

LAS VEGAS - April 12, 2023 - PRLog -- As the healthcare industry continues to adopt advanced technologies, hyper-automation has emerged as a promising solution to improve healthcare outcomes and patient experiences. Hyper-automation refers to the use of artificial intelligence (AI), machine learning (ML), and robotic process automation (RPA) to automate complex processes and tasks in healthcare delivery. However, as with any new technology, there are also risks associated with hyper-automation, particularly in relation to the potential for scams and fraud.

Panelists at Health 2.0 Conference scheduled on July 10-12, 2023, at Caesars Forum in Las Vegas, USA, will review hyper-automation in healthcare, all the scams, spam, and frauds being facilitated due to automation along with effective preventive measures being discussed amongst industry experts and veterans.

Hyper-automation technologies rely on data to learn and improve their performance. This data may include sensitive patient information, such as medical records, diagnosis codes, and treatment histories. Scammers may use hyper-automation technologies to steal patient data by hacking into healthcare systems or using social engineering tactics to trick patients into divulging sensitive information. Additionally, healthcare organizations may inadvertently expose patient data through poor data management practices.

Experts who will be speaking at the Health 2.0 Conference explained how hyper-automation technologies could also be susceptible to program bias, where algorithms may make decisions based on flawed or incomplete data. In healthcare, program bias can have serious consequences, leading to misdiagnosis and inadequate treatment scams involving unqualified healthcare providers scamming patients, which may lead to financial and health-related consequences.

Scammers may use hyper-automation technologies to evade regulatory requirements and commit fraud. For example, scammers may use hyper-automation to generate false billing claims, or a pharmaceutical company may use hyper-automation to manipulate clinical trial data. Additionally, hyper-automation technologies can circumvent regulatory requirements related to patient safety, such as those related to drug interactions or medical device safety.

Regular and effective monitoring and evaluation of hyper-automation technologies are necessary to ensure they operate effectively and comply with regulatory requirements. This can include conducting regular risk assessments, auditing algorithms for bias and discrimination, and engaging with patients and staff to gather feedback on using these technologies.

Global health events, notably Health 2.0 Conference, help professionals stay up to date on the latest challenges and fresh perspectives in the industry, helping educate them and preventing further scams, spam, and fraud from occurring. To be a part of this global health conference in Dubai and the USA in 2023, feel free to visit www.health2conf.com